{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:45:03Z","timestamp":1792021503095,"version":"4.4.0"},"reference-count":349,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","award":["R01AG070873"],"award-info":[{"award-number":["R01AG070873"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG072540"],"award-info":[{"award-number":["R01AG072540"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG056363"],"award-info":[{"award-number":["RF1AG056363"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008474","name":"New Jersey Commission on Brain Injury Research","doi-asserted-by":"publisher","award":["CBIR25IRG005"],"award-info":[{"award-number":["CBIR25IRG005"]}],"id":[{"id":"10.13039\/100008474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008474","name":"New Jersey Commission on Brain Injury Research","doi-asserted-by":"publisher","award":["CBIR23IRG008"],"award-info":[{"award-number":["CBIR23IRG008"]}],"id":[{"id":"10.13039\/100008474","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pharmthera.2026.109130","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:21:03Z","timestamp":1791933663000},"page":"109130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mitochondrial dysfunction in Alzheimer\u2019s disease: mechanisms, pathogenic interplay, and therapeutic opportunities"],"prefix":"10.1016","volume":"288","author":[{"given":"Baomin","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sun-Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb0005","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1007\/s12035-022-02937-w","article-title":"Mitochondrial transfusion improves mitochondrial function through up-regulation of mitochondrial complex II protein subunit SDHB in the hippocampus of aged mice","volume":"59","author":"Adlimoghaddam","year":"2022","journal-title":"Molecular Neurobiology"},{"issue":"24","key":"10.1016\/j.pharmthera.2026.109130_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262411995","article-title":"Glial cells in the early stages of neurodegeneration: pathogenesis and therapeutic targets","volume":"26","author":"Ahremenko","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","article-title":"On the path to 2025: understanding the Alzheimer's disease continuum","volume":"9","author":"Aisen","year":"2017","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.freeradbiomed.2025.11.040","article-title":"APOE4 impairs Nrf2-PINK1\/Parkin-dependent mitochondrial clearance through disrupted antioxidant and mitophagy signaling","volume":"243","author":"Akhter","year":"2026","journal-title":"Free Radical Biology & Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nbd.2010.04.011","article-title":"Preclinical Alzheimer disease: brain oxidative stress. Abeta peptide and proteomics","volume":"39","author":"Aluise","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb0030","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer's disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb0040","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.201308006","article-title":"The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission","volume":"204","author":"Anand","year":"2014","journal-title":"The Journal of Cell Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200207030","article-title":"Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells","volume":"161","author":"Anandatheerthavarada","year":"2003","journal-title":"The Journal of Cell Biology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109130_bb0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41419-021-04237-y","article-title":"Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease","volume":"12","author":"Andersen","year":"2021","journal-title":"Cell Death & Disease"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s42255-019-0073-4","article-title":"The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans","volume":"1","author":"Andreux","year":"2019","journal-title":"Nature Metabolism"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41419-017-0215-0","article-title":"A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease","volume":"9","author":"Area-Gomez","year":"2018","journal-title":"Cell Death & Disease"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb0060","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.2353\/ajpath.2009.090219","article-title":"Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria","volume":"175","author":"Area-Gomez","year":"2009","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0070","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/630865","article-title":"The pathogenesis of Alzheimer's disease: a reevaluation of the \"amyloid cascade hypothesis\"","volume":"2011","author":"Armstrong","year":"2011","journal-title":"International Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0075","article-title":"IP(3)R at ER-mitochondrial contact sites: beyond the IP(3)R-GRP75-VDAC1 Ca(2+) funnel","volume":"6","author":"Atakpa-Adaji","year":"2023","journal-title":"Contact (Thousand Oaks)"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb0080","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","article-title":"An energy budget for signaling in the grey matter of the brain","volume":"21","author":"Attwell","year":"2001","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jnc.14471","article-title":"Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration","volume":"147","author":"Audano","year":"2018","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0090","doi-asserted-by":"crossref","DOI":"10.1177\/26331055261422166","article-title":"Stage-dependent function of astrocytes in Alzheimer's disease: a review","volume":"21","author":"Azari","year":"2026","journal-title":"Neuroscience Insights"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109130_bb0095","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1523\/JNEUROSCI.2385-16.2017","article-title":"Inhibition of Drp1 ameliorates synaptic depression, abeta deposition, and cognitive impairment in an Alzheimer's disease model","volume":"37","author":"Baek","year":"2017","journal-title":"The Journal of Neuroscience"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109130_bb0100","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1523\/JNEUROSCI.2385-16.2017","article-title":"Inhibition of Drp1 ameliorates synaptic depression, A\u03b2 deposition, and cognitive impairment in an Alzheimer's disease model","volume":"37","author":"Baek","year":"2017","journal-title":"The Journal of Neuroscience"},{"issue":"38","key":"10.1016\/j.pharmthera.2026.109130_bb0105","doi-asserted-by":"crossref","first-page":"13852","DOI":"10.1074\/jbc.REV118.000828","article-title":"Mitochondrial plasticity in cell fate regulation","volume":"294","author":"Bahat","year":"2019","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0110","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","article-title":"A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer's disease","volume":"30","author":"Baik","year":"2019","journal-title":"Cell Metabolism"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb0115","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/jnc.14564","article-title":"Lysosome biogenesis in health and disease","volume":"148","author":"Bajaj","year":"2019","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051772","article-title":"PINK1\/Parkin mediated mitophagy, Ca(2+) signalling, and ER-mitochondria contacts in Parkinson's disease","volume":"21","author":"Barazzuol","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5152029","article-title":"Creatine prevents the structural and functional damage to mitochondria in myogenic, oxidatively stressed C2C12 cells and restores their differentiation capacity","volume":"2016","author":"Barbieri","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109130_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23168979","article-title":"Targeting NLRP3-mediated neuroinflammation in Alzheimer's disease treatment","volume":"23","author":"Barczuk","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0135","article-title":"Resveratrol activates antioxidant protective mechanisms in cellular models of Alzheimer's disease inflammation","volume":"13","author":"Bartra","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11483","article-title":"Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease","volume":"7","author":"Beck","year":"2016","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0145","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41380-024-02746-8","article-title":"Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer's disease astrocytes","volume":"30","author":"Bell","year":"2025","journal-title":"Molecular Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb0150","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41418-023-01187-0","article-title":"Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions","volume":"30","author":"Bernardi","year":"2023","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2015.10.011","article-title":"Mitochondrial fusion\/fission dynamics in neurodegeneration and neuronal plasticity","volume":"90","author":"Bertholet","year":"2016","journal-title":"Neurobiology of Disease"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109130_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166798","article-title":"Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease","volume":"1869","author":"Bhatti","year":"2023","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0165","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajpath.2015.10.004","article-title":"Altered mitochondrial DNA methylation pattern in Alzheimer disease-related pathology and in Parkinson disease","volume":"186","author":"Blanch","year":"2016","journal-title":"The American Journal of Pathology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb0170","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00001756-199306000-00051","article-title":"A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissue","volume":"4","author":"Blanchard","year":"1993","journal-title":"Neuroreport"},{"issue":"7986","key":"10.1016\/j.pharmthera.2026.109130_bb0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-023-06537-z","article-title":"The power and potential of mitochondria transfer","volume":"623","author":"Borcherding","year":"2023","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109130_bb0180","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","article-title":"Accelerating Alzheimer's therapeutic development: The past and future of clinical trials","volume":"186","author":"Boxer","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0185","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jnc.12444","article-title":"Nucleic acid oxidation: an early feature of Alzheimer's disease","volume":"128","author":"Bradley-Whitman","year":"2014","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0190","first-page":"111","article-title":"Alzheimer's disease and Meynert's nucleus basalis. An anatomo- clinical point of view","volume":"12","author":"Brion","year":"1986","journal-title":"Encephale"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb0195","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb0200","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035154","article-title":"Calcium sensors in neuronal function and dysfunction","volume":"11","author":"Burgoyne","year":"2019","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00023210-200317090-00004","article-title":"The glutamatergic system and Alzheimer's disease: therapeutic implications","volume":"17","author":"Butterfield","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0210","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/509654","article-title":"Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer's disease","volume":"2015","author":"Cabezas-Opazo","year":"2015","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0230","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13316","article-title":"Aerobic exercise improves astrocyte mitochondrial quality and transfer to neurons in a mouse model of Alzheimer's disease","volume":"35","author":"Cai","year":"2025","journal-title":"Brain Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010150","article-title":"Mitophagy in Alzheimer's disease and other age-related neurodegenerative diseases","volume":"9","author":"Cai","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0220","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JAD-160726","article-title":"Mitochondrial aspects of synaptic dysfunction in Alzheimer's disease","volume":"57","author":"Cai","year":"2017","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2020.08.002","article-title":"Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma","volume":"246-247","author":"Cai","year":"2020","journal-title":"Cancer Genetics"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0235","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tins.2020.10.004","article-title":"Mitochondria and calcium in Alzheimer's disease: from cell signaling to neuronal cell death","volume":"44","author":"Calvo-Rodriguez","year":"2021","journal-title":"Trends in Neurosciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1124\/pr.110.003905","article-title":"Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?","volume":"64","author":"Cant\u00f3","year":"2012","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13578-025-01519-2","article-title":"PGC-1\u03b1: key regulator of mitochondrial biogenesis and cellular differentiation in metabolic and regenerative tissues","volume":"16","author":"Cao","year":"2025","journal-title":"Cell & Bioscience"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109130_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313059","article-title":"Mitochondrial biogenesis in neurons: how and where","volume":"22","author":"Cardanho-Ramos","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109130_bb0255","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70069","article-title":"VDAC1-targeted NHK1 peptide recovers mitochondrial dysfunction counteracting amyloid-beta oligomers toxicity in Alzheimer's disease","volume":"24","author":"Cavallaro","year":"2025","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0260","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3233\/JAD-170613","article-title":"Mitochondrial translocase of the outer membrane alterations may underlie dysfunctional oxidative phosphorylation in Alzheimer's disease","volume":"61","author":"Chai","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0265","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fnagi.2019.00311","article-title":"Dysfunctional mitochondria and mitophagy as drivers of Alzheimer's disease pathogenesis","volume":"11","author":"Chakravorty","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109130_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052056","article-title":"Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease","volume":"7","author":"Chakroborty","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009524.pub2","article-title":"Latrepirdine for Alzheimer's disease","volume":"2015","author":"Chau","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109130_bb0280","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1074\/jbc.M115.691352","article-title":"MicroRNA-7 regulates the function of mitochondrial permeability transition pore by targeting VDAC1 expression","volume":"291","author":"Chaudhuri","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2026.109130_bb0285","first-page":"iii","article-title":"Journal of Neurochemistry special issue on Alzheimer's disease: 'amyloid cascade hypothesis--20 years on'","volume":"120","author":"Checler","year":"2012","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.767560","article-title":"Conditional knockout of Pdha1 in mouse hippocampus impairs cognitive function: the possible involvement of lactate","volume":"15","author":"Chen","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0295","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202504635R","article-title":"Metformin activates AMPK to restrain mitochondrial ROS-driven necroptosis in cadmium neurotoxicity","volume":"40","author":"Chen","year":"2026","journal-title":"The FASEB Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb0300","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jalz.2018.01.015","article-title":"The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes","volume":"14","author":"Chiba-Falek","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"5923","key":"10.1016\/j.pharmthera.2026.109130_bb0305","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1171091","article-title":"S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury","volume":"324","author":"Cho","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154923","article-title":"Regulation of NAD(+) metabolism in aging and disease","volume":"126","author":"Chu","year":"2022","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb0315","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/hmg\/ddr618","article-title":"Sustained expression of PGC-1alpha in the rat nigrostriatal system selectively impairs dopaminergic function","volume":"21","author":"Ciron","year":"2012","journal-title":"Human Molecular Genetics"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2026.109130_bb0320","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.mito.2007.02.007","article-title":"Mitochondrial targeting of quinones: therapeutic implications","volume":"7","author":"Cochem\u00e9","year":"2007","journal-title":"Mitochondrion"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0325","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nature Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109130_bb0330","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70294","article-title":"The energetic collapse of the Alzheimer's brain: metabolic inflexibility across cells and networks","volume":"169","author":"Constantino","year":"2025","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0335","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11064-014-1377-0","article-title":"PPAR\u03b3 and PGC-1\u03b1 as therapeutic targets in Parkinson's","volume":"40","author":"Corona","year":"2015","journal-title":"Neurochemical Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0340","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s12035-018-1157-y","article-title":"Resveratrol induces brain resilience against Alzheimer neurodegeneration through proteostasis enhancement","volume":"56","author":"Corpas","year":"2019","journal-title":"Molecular Neurobiology"},{"issue":"29","key":"10.1016\/j.pharmthera.2026.109130_bb0345","doi-asserted-by":"crossref","first-page":"10726","DOI":"10.1073\/pnas.0403649101","article-title":"Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication","volume":"101","author":"Coskun","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109130_bb0350","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tcb.2018.02.009","article-title":"Endoplasmic reticulum-mitochondrial contactology: structure and signaling functions","volume":"28","author":"Csordas","year":"2018","journal-title":"Trends in Cell Biology"},{"issue":"25","key":"10.1016\/j.pharmthera.2026.109130_bb0355","doi-asserted-by":"crossref","first-page":"23802","DOI":"10.1074\/jbc.M500356200","article-title":"Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice","volume":"280","author":"David","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109130_bb0360","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0365","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fnins.2019.00292","article-title":"The role of PGC-1\u03b1\/UCP2 signaling in the beneficial effects of physical exercise on the brain","volume":"13","author":"de Oliveira Bristot","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb0370","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.bbamcr.2015.04.008","article-title":"Structure and function of the mitochondrial calcium uniporter complex","volume":"1853","author":"De Stefani","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0375","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3233\/JAD-160953","article-title":"Localization and processing of the amyloid-beta protein precursor in mitochondria-associated membranes","volume":"55","author":"Del Prete","year":"2017","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0380","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14737175.2021.1847645","article-title":"Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system","volume":"21","author":"Demar\u00e9","year":"2021","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb0390","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4103\/1673-5374.392880","article-title":"Probing the endoplasmic reticulum-mitochondria interaction in Alzheimer's disease: searching far and wide","volume":"19","author":"Dematteis","year":"2024","journal-title":"Neural Regeneration Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb0385","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41419-020-02911-1","article-title":"Proteomic analysis links alterations of bioenergetics, mitochondria-ER interactions and proteostasis in hippocampal astrocytes from 3xTg-AD mice","volume":"11","author":"Dematteis","year":"2020","journal-title":"Cell Death & Disease"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109130_bb0395","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1111\/bph.14697","article-title":"Exploring mitochondrial cholesterol signalling for therapeutic intervention in neurological conditions","volume":"176","author":"Desai","year":"2019","journal-title":"British Journal of Pharmacology"},{"issue":"35","key":"10.1016\/j.pharmthera.2026.109130_bb0400","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","article-title":"Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction","volume":"26","author":"Devi","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2025.12.002","article-title":"Microglia in systemic neuroimmune communication: functions beyond phagocytosis","author":"Di Pietro","year":"2026","journal-title":"Trends in Immunology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109130_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079977","article-title":"Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb0415","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.jmb.2019.12.035","article-title":"Autophagy induction as a therapeutic strategy for neurodegenerative diseases","volume":"432","author":"Djajadikerta","year":"2020","journal-title":"Journal of Molecular Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0420","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae005","article-title":"New horizons in the diagnosis and management of Alzheimer's disease in older adults","volume":"53","author":"Dolphin","year":"2024","journal-title":"Age and Ageing"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb0425","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nm.1868","article-title":"Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease","volume":"14","author":"Du","year":"2008","journal-title":"Nature Medicine"},{"issue":"43","key":"10.1016\/j.pharmthera.2026.109130_bb0430","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb0435","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tins.2013.03.002","article-title":"Why size matters - balancing mitochondrial dynamics in Alzheimer's disease","volume":"36","author":"DuBoff","year":"2013","journal-title":"Trends in Neurosciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0440","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1096\/fj.13-236331","article-title":"PGC-1alpha overexpression exacerbates beta-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease","volume":"28","author":"Dumont","year":"2014","journal-title":"The FASEB Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.09.009","article-title":"Therapies for mitochondrial diseases and current clinical trials","volume":"122","author":"El-Hattab","year":"2017","journal-title":"Molecular Genetics and Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036153","article-title":"Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I","volume":"7","author":"Erb","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0455","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer's disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0465","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/421452","article-title":"Promising genetic biomarkers of preclinical Alzheimer's disease: the influence of APOE and TOMM40 on brain integrity","volume":"2012","author":"Ferencz","year":"2012","journal-title":"International Journal of Alzheimer's Disease"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0470","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3233\/JAD-131499","article-title":"Reduced levels of mitochondrial complex I subunit NDUFB8 and linked complex I + III oxidoreductase activity in the TgCRND8 mouse model of Alzheimer's disease","volume":"39","author":"Francis","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0475","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1038\/s41467-022-32592-7","article-title":"Earlier Alzheimer's disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading","volume":"13","author":"Frontzkowski","year":"2022","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0480","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13543784.2017.1265504","article-title":"Pioglitazone for the treatment of Alzheimer's disease","volume":"26","author":"Galimberti","year":"2017","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030770","article-title":"Intracellular calcium dysregulation by the Alzheimer's disease-linked protein presenilin 2","volume":"21","author":"Galla","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0495","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0490","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tcb.2020.09.008","article-title":"Mitochondrial fusion: the machineries in and out","volume":"31","author":"Gao","year":"2021","journal-title":"Trends in Cell Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0500","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physrev.00041.2020","article-title":"Mitochondrial calcium exchange in physiology and disease","volume":"102","author":"Garbincius","year":"2022","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0505","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/NDT.S350939","article-title":"Role of calcium homeostasis in Alzheimer's disease","volume":"18","author":"Ge","year":"2022","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0510","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2010.229","article-title":"A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease","volume":"68","author":"Geldmacher","year":"2011","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0515","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","article-title":"The cell biology of mitochondrial membrane dynamics","volume":"21","author":"Giacomello","year":"2020","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0520","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.410440414","article-title":"Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670\/671 mutation","volume":"44","author":"Gibson","year":"1998","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb0525","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","article-title":"Mitochondria and cell death","volume":"26","author":"Glover","year":"2024","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101039","article-title":"Astrocyte mitochondria: Central players and potential therapeutic targets for neurodegenerative diseases and injury","volume":"59","author":"Gollihue","year":"2020","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0535","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8152373","article-title":"Neuroprotective mechanisms of resveratrol in Alzheimer's disease: Role of SIRT1","volume":"2018","author":"Gomes","year":"2018","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb0545","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s12035-023-03231-z","article-title":"Immortalized Alzheimer's disease astrocytes: Characterization of their proteolytic systems","volume":"60","author":"Gong","year":"2023","journal-title":"Molecular Neurobiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0540","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nature Reviews. Immunology"},{"issue":"36","key":"10.1016\/j.pharmthera.2026.109130_bb0550","doi-asserted-by":"crossref","first-page":"12128","DOI":"10.1523\/JNEUROSCI.2474-10.2010","article-title":"NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice","volume":"30","author":"Goussakov","year":"2010","journal-title":"The Journal of Neuroscience"},{"issue":"28","key":"10.1016\/j.pharmthera.2026.109130_bb0555","first-page":"E3699","article-title":"Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques","volume":"112","author":"Gowrishankar","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0560","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0011-393X(03)00059-6","article-title":"Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on","volume":"64","author":"Grossberg","year":"2003","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0565","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review","volume":"13","author":"Grygiel-G\u00f3rniak","year":"2014","journal-title":"Nutrition Journal"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0570","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fgene.2019.00435","article-title":"Regulation of mitochondrial biogenesis as a way for active longevity: Interaction between the Nrf2 and PGC-1\u03b1 signaling pathways","volume":"10","author":"Gureev","year":"2019","journal-title":"Frontiers in Genetics"},{"issue":"7883","key":"10.1016\/j.pharmthera.2026.109130_bb0575","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","article-title":"Neurotoxic reactive astrocytes induce cell death via saturated lipids","volume":"599","author":"Guttenplan","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109130_bb0580","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0585","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010116","article-title":"Mfn2 ablation in the adult mouse hippocampus and cortex causes neuronal death","volume":"9","author":"Han","year":"2020","journal-title":"Cells"},{"issue":"35","key":"10.1016\/j.pharmthera.2026.109130_bb0590","doi-asserted-by":"crossref","first-page":"13145","DOI":"10.1073\/pnas.0806192105","article-title":"The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae","volume":"105","author":"Hansson Petersen","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb0595","first-page":"495","article-title":"Alzheimer drug lecanemab gains traditional FDA approval","volume":"330","author":"Harris","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0600","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3940(98)00654-5","article-title":"CI-ATPase and Na+\/K(+)-ATPase activities in Alzheimer's disease brains","volume":"254","author":"Hattori","year":"1998","journal-title":"Neuroscience Letters"},{"issue":"7613","key":"10.1016\/j.pharmthera.2026.109130_bb0605","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature18928","article-title":"Transfer of mitochondria from astrocytes to neurons after stroke","volume":"535","author":"Hayakawa","year":"2016","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109130_bb0610","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1073\/pnas.1300677110","article-title":"Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models","volume":"110","author":"Hedskog","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0615","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13441","article-title":"Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Abeta plaques by iGluSnFR two-photon imaging","volume":"7","author":"Hefendehl","year":"2016","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0620","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neurobiolaging.2020.10.001","article-title":"Alzheimer amyloid-beta- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood","volume":"97","author":"Hendrix","year":"2021","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0625","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb0635","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1002\/alz.13847","article-title":"Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions","volume":"20","author":"Hou","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154056","article-title":"Biochanin A alleviates cognitive impairment and hippocampal mitochondrial damage in ovariectomized APP\/PS1 mice","volume":"100","author":"Hou","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102470","article-title":"Nrf1 is an indispensable redox-determining factor for mitochondrial homeostasis by integrating multi-hierarchical regulatory networks","volume":"57","author":"Hu","year":"2022","journal-title":"Redox Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0650","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13045-025-01727-w","article-title":"Mitophagy's impacts on cancer and neurodegenerative diseases: implications for future therapies","volume":"18","author":"Huang","year":"2025","journal-title":"Journal of Hematology & Oncology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0655","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/acs.analchem.4c03646","article-title":"Simultaneous imaging of pH and peroxynitrite in the endoplasmic reticulum and mitochondria: Revealing organelle interactions in Alzheimer's disease pathogenesis","volume":"97","author":"Huang","year":"2025","journal-title":"Analytical Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0645","first-page":"1155","article-title":"Glycometabolic reprogramming of microglia in neurodegenerative diseases: Insights from neuroinflammation","volume":"15","author":"Huang","year":"2024","journal-title":"Aging and Disease"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109130_bb0660","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3174\/ajnr.A3695","article-title":"PET approaches for diagnosis of dementia","volume":"35","author":"Ishii","year":"2014","journal-title":"AJNR. American Journal of Neuroradiology"},{"issue":"6505","key":"10.1016\/j.pharmthera.2026.109130_bb0665","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.aba9760","article-title":"Mitochondrial dynamics in postmitotic cells regulate neurogenesis","volume":"369","author":"Iwata","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0670","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1038\/s41467-019-11813-6","article-title":"Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer's disease","volume":"10","author":"Jadiya","year":"2019","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0675","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-026-00540-w","article-title":"Mitochondrial DNA: A molecular switch driving sterile neuroinflammation","volume":"15","author":"Jauhari","year":"2026","journal-title":"Transl Neurodegener"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0680","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3233\/JAD-191258","article-title":"Targeting mitophagy in Alzheimer's disease","volume":"78","author":"Jayatunga","year":"2020","journal-title":"Journal of Alzheimer's Disease"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0685","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/157015912804499528","article-title":"Pyruvate dehydrogenase kinases in the nervous system: Their principal functions in neuronal-glial metabolic interaction and neuro-metabolic disorders","volume":"10","author":"Jha","year":"2012","journal-title":"Current Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030649","article-title":"Mitochondrial permeability transition: A pore intertwines brain aging and Alzheimer's disease","volume":"10","author":"Jia","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0695","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-018-0238-8","article-title":"Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex","volume":"13","author":"Jiang","year":"2018","journal-title":"Molecular Neurodegeneration"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0700","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12912","article-title":"Dynamin-like protein 1 cleavage by calpain in Alzheimer's disease","volume":"18","author":"Jiang","year":"2019","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061345","article-title":"Mitochondrial MicroRNAs in aging and neurodegenerative diseases","volume":"9","author":"John","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb0715","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41593-019-0486-0","article-title":"Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration","volume":"22","author":"Joshi","year":"2019","journal-title":"Nature Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb0710","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.18632\/oncotarget.23640","article-title":"Drp1\/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease","volume":"9","author":"Joshi","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0720","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-025-00825-0","article-title":"Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research","volume":"20","author":"Jung","year":"2025","journal-title":"Molecular Neurodegeneration"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109130_bb0730","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1093\/hmg\/ddw312","article-title":"Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease","volume":"25","author":"Kandimalla","year":"2016","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0735","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/hmg\/ddx381","article-title":"Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease","volume":"27","author":"Kandimalla","year":"2018","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0725","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bbadis.2015.12.018","article-title":"Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis","volume":"1862","author":"Kandimalla","year":"2016","journal-title":"Biochimica et Biophysica Acta"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0740","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1474-4422(10)70277-5","article-title":"Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease","volume":"10","author":"Kapogiannis","year":"2011","journal-title":"Lancet Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0745","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2011-101356","article-title":"PPARgamma co-activator-1alpha (PGC-1alpha) reduces amyloid-beta generation through a PPARgamma-dependent mechanism","volume":"25","author":"Katsouri","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109130_bb0750","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111720","article-title":"From plaques to pathways in Alzheimer's disease: The mitochondrial-neurovascular-metabolic hypothesis","volume":"25","author":"Kazemeini","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0755","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer's disease: Cellular and molecular mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends in Neurosciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0760","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archneurol.2009.334","article-title":"A randomized, placebo-controlled trial of latrepirdine in Huntington disease","volume":"67","author":"Kieburtz","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0770","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.freeradbiomed.2015.11.015","article-title":"Peroxiredoxin 5 prevents amyloid-beta oligomer-induced neuronal cell death by inhibiting ERK-Drp1-mediated mitochondrial fragmentation","volume":"90","author":"Kim","year":"2016","journal-title":"Free Radical Biology & Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109130_bb0775","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/j.bbamcr.2016.09.003","article-title":"Abeta-induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis","volume":"1863","author":"Kim","year":"2016","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0780","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","article-title":"Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway","volume":"55","author":"Kim","year":"2023","journal-title":"Experimental & Molecular Medicine"},{"issue":"24","key":"10.1016\/j.pharmthera.2026.109130_bb0765","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/S0024-3205(01)01074-8","article-title":"The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with down syndrome and Alzheimer's disease","volume":"68","author":"Kim","year":"2001","journal-title":"Life Sciences"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb0785","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jnr.24397","article-title":"Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice","volume":"97","author":"Klimova","year":"2019","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharmacological Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0795","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1745691617718356","article-title":"Our (mother's) mitochondria and our mind","volume":"13","author":"Kramer","year":"2018","journal-title":"Perspectives on Psychological Science"},{"issue":"7844","key":"10.1016\/j.pharmthera.2026.109130_bb0800","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41586-021-03214-x","article-title":"Function and regulation of the divisome for mitochondrial fission","volume":"590","author":"Kraus","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb0805","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10571-020-00871-w","article-title":"Immortalised hippocampal astrocytes from 3xTG-Ad mice fail to support BBB integrity in vitro: Role of extracellular vesicles in glial-endothelial communication","volume":"41","author":"Kriauciunaite","year":"2021","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb0810","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.neurobiolaging.2011.08.009","article-title":"Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease","volume":"33","author":"Krishnan","year":"2012","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0815","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1038\/s41467-025-61239-6","article-title":"Biotechnological approaches and therapeutic potential of mitochondria transfer and transplantation","volume":"16","author":"Kubat","year":"2025","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101874","article-title":"Interplay of mitochondria-associated membrane proteins and autophagy: Implications in neurodegeneration","volume":"76","author":"Kulkarni","year":"2024","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102182","article-title":"MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease","volume":"48","author":"Kumar","year":"2021","journal-title":"Redox Biology"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109130_bb0830","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1093\/hmg\/ddx226","article-title":"Aqua-soluble DDQ reduces the levels of Drp1 and A\u03b2 and inhibits abnormal interactions between A\u03b2 and Drp1 and protects Alzheimer's disease neurons from A\u03b2- and Drp1-induced mitochondrial and synaptic toxicities","volume":"26","author":"Kuruva","year":"2017","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0835","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.626636","article-title":"A systematic review of glucose transport alterations in Alzheimer's disease","volume":"15","author":"Kyrtata","year":"2021","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105753","article-title":"Neuron-astrocyte transmitophagy is altered in Alzheimer's disease","volume":"170","author":"Lampinen","year":"2022","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0845","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12967-025-07290-9","article-title":"Astrocytic mitochondrial transfer: A new horizon for metabolic rescue and precision therapy in ischemic stroke","volume":"24","author":"Lan","year":"2026","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0860","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuro.2018.07.011","article-title":"Isoliquiritigenin attenuates glutamate-induced mitochondrial fission via calcineurin-mediated Drp1 dephosphorylation in HT22 hippocampal neuron cells","volume":"68","author":"Lee","year":"2018","journal-title":"Neurotoxicology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb0855","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.celrep.2015.07.050","article-title":"Presenilin 1 maintains lysosomal Ca(2+) homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification","volume":"12","author":"Lee","year":"2015","journal-title":"Cell Reports"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb0865","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","article-title":"Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of Abeta in neurons, yielding senile plaques","volume":"25","author":"Lee","year":"2022","journal-title":"Nature Neuroscience"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109130_bb0850","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","article-title":"Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations","volume":"141","author":"Lee","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0870","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13195-019-0558-0","article-title":"APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain","volume":"11","author":"Lefterov","year":"2019","journal-title":"Alzheimer's Research & Therapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb0875","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41593-020-00764-7","article-title":"Molecular characterization of selectively vulnerable neurons in Alzheimer's disease","volume":"24","author":"Leng","year":"2021","journal-title":"Nature Neuroscience"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb0880","first-page":"E1279","article-title":"Intracellular Ca(2+) stores control in vivo neuronal hyperactivity in a mouse model of Alzheimer's disease","volume":"115","author":"Lerdkrai","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb0885","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/jnr.24042","article-title":"Mitochondrial biogenesis in neurodegeneration","volume":"95","author":"Li","year":"2017","journal-title":"Journal of Neuroscience Research"},{"issue":"2-3","key":"10.1016\/j.pharmthera.2026.109130_bb0890","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0304-3940(90)90227-Z","article-title":"Changes in Na+,K(+)-ATPase, Ca2(+)-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease","volume":"112","author":"Liguri","year":"1990","journal-title":"Neuroscience Letters"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb0895","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","article-title":"Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases","volume":"43","author":"Lin","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0900","article-title":"NMN reverses D-galactose-induced neurodegeneration and enhances the intestinal barrier of mice by activating the Sirt1 pathway","volume":"16","author":"Lin","year":"2025","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0915","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40779-024-00536-5","article-title":"Mitochondrial quality control in human health and disease","volume":"11","author":"Liu","year":"2024","journal-title":"Military Medical Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0925","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","article-title":"Energy metabolism in health and diseases","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109130_bb0930","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70259","article-title":"Mitochondria-associated endoplasmic reticulum membranes in human health and diseases","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0920","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.04.009","article-title":"Mitochondrial DNA leakage and cGas\/STING pathway in microglia: Crosstalk between neuroinflammation and neurodegeneration","volume":"548","author":"Liu","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111212","article-title":"Mitochondrial fission and fusion: A dynamic role in aging and potential target for age-related disease","volume":"186","author":"Liu","year":"2020","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0910","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.freeradbiomed.2020.04.002","article-title":"The mechanism of CaMK2\u03b1-MCU-mitochondrial oxidative stress in bupivacaine-induced neurotoxicity","volume":"152","author":"Liu","year":"2020","journal-title":"Free Radical Biology & Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0935","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/15548627.2025.2581217","article-title":"Autophagy and mitophagy at the synapse and beyond: Implications for learning, memory and neurological disorders","volume":"22","author":"Lu","year":"2026","journal-title":"Autophagy"},{"issue":"7652","key":"10.1016\/j.pharmthera.2026.109130_bb0940","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature22082","article-title":"The mitochondrial Na(+)\/Ca(2+) exchanger is essential for Ca(2+) homeostasis and viability","volume":"545","author":"Luongo","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb0945","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1159\/000533602","article-title":"Mitochondrial damage-associated molecular patterns and metabolism in the regulation of innate immunity","volume":"15","author":"Lyu","year":"2023","journal-title":"Journal of Innate Immunity"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb0950","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2174\/1567205011666140505111354","article-title":"Early detection of cerebral glucose uptake changes in the 5XFAD mouse","volume":"11","author":"Macdonald","year":"2014","journal-title":"Current Alzheimer Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0955","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/BST20170501","article-title":"Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: Can mitochondria be targeted therapeutically?","volume":"46","author":"Macdonald","year":"2018","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0960","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1281882","article-title":"Targeting CaN\/NFAT in Alzheimer's brain degeneration","volume":"14","author":"Mackiewicz","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109130_bb0965","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294312","article-title":"Trehalose enhances mitochondria deficits in human NPC1 mutant fibroblasts but disrupts mouse Purkinje cell dendritic growth ex vivo","volume":"18","author":"MacLeod","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb0970","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1083\/jcb.201106120","article-title":"Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons","volume":"196","author":"Maday","year":"2012","journal-title":"The Journal of Cell Biology"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109130_bb0985","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: Implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb0990","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/hmg\/ddy042","article-title":"Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer's disease","volume":"27","author":"Manczak","year":"2018","journal-title":"Human Molecular Genetics"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2026.109130_bb0980","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.3233\/JAD-2010-100564","article-title":"Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons","volume":"20","author":"Manczak","year":"2010","journal-title":"Journal of Alzheimer's Disease"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109130_bb0975","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1093\/hmg\/dds360","article-title":"Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease","volume":"21","author":"Manczak","year":"2012","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2026.109130_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119985","article-title":"Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations","volume":"285","author":"Mani","year":"2021","journal-title":"Life Sciences"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb1000","doi-asserted-by":"crossref","DOI":"10.3390\/nu13082758","article-title":"Creatine supplementation upregulates mTORC1 signaling and markers of synaptic plasticity in the dentate gyrus while ameliorating LPS-induced cognitive impairment in female rats","volume":"13","author":"Mao","year":"2021","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb1005","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2174\/138955709788681627","article-title":"ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease","volume":"9","author":"Marques","year":"2009","journal-title":"Mini Reviews in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fnmol.2017.00291","article-title":"Mitophagy Failure in Fibroblasts and iPSC-Derived Neurons of Alzheimer's Disease-Associated Presenilin 1 Mutation","volume":"10","author":"Martin-Maestro","year":"2017","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb1010","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/hmg\/ddv616","article-title":"PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease","volume":"25","author":"Martin-Maestro","year":"2016","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101868","article-title":"Involvement of mitochondria in Alzheimer's disease pathogenesis and their potential as targets for phytotherapeutics","volume":"76","author":"Maruthiyodan","year":"2024","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb1025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ana.410390508","article-title":"Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease","volume":"39","author":"Mastrogiacoma","year":"1996","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb1030","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1993.tb07436.x","article-title":"Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease","volume":"61","author":"Mastrogiacomo","year":"1993","journal-title":"Journal of Neurochemistry"},{"issue":"7869","key":"10.1016\/j.pharmthera.2026.109130_bb1035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","article-title":"Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease","volume":"595","author":"McAlpine","year":"2021","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb1040","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1080\/15548627.2018.1505154","article-title":"MFN2 retrotranslocation boosts mitophagy by uncoupling mitochondria from the ER","volume":"14","author":"McLelland","year":"2018","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109130_bb1045","article-title":"Aducanumab in Alzheimer's disease: A comparative study of its effects on dementia and mild cognitive impairment","volume":"16","author":"Medel S\u00e1nchez","year":"2024","journal-title":"Cureus"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109130_bb1050","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1021\/acs.jpcb.0c01712","article-title":"Identification of structural calcium binding sites in membrane-bound presenilin 1 and 2","volume":"124","author":"Mehra","year":"2020","journal-title":"The Journal of Physical Chemistry. B"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1055","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1400544","article-title":"Neurotoxic beta-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons","volume":"16","author":"Meng","year":"2024","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb1060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","article-title":"Sugar for the brain: The role of glucose in physiological and pathological brain function","volume":"36","author":"Mergenthaler","year":"2013","journal-title":"Trends in Neurosciences"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109130_bb1065","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's disease","volume":"384","author":"Mintun","year":"2021","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109130_bb1070","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","article-title":"The role of mitochondria in neurodegenerative diseases: The lesson from Alzheimer's DISEASE and Parkinson's disease","volume":"57","author":"Monzio Compagnoni","year":"2020","journal-title":"Molecular Neurobiology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb1075","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2337\/dc13-0229","article-title":"Increased risk of cognitive impairment in patients with diabetes is associated with metformin","volume":"36","author":"Moore","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/neu.2020.43","article-title":"Systematic review and meta-analysis on the role of mitochondrial cytochrome c oxidase in Alzheimer's disease","volume":"33","author":"Morais","year":"2021","journal-title":"Acta Neuropsychiatrica"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb1085","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1111\/brv.12764","article-title":"The mitochondrial permeability transition pore: an evolving concept critical for cell life and death","volume":"96","author":"Morciano","year":"2021","journal-title":"Biological Reviews of the Cambridge Philosophical Society"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb1090","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.freeradbiomed.2008.01.002","article-title":"Nucleic acid oxidation in Alzheimer disease","volume":"44","author":"Moreira","year":"2008","journal-title":"Free Radical Biology & Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb1095","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/acs.jmedchem.8b01530","article-title":"Amyloid-binding alcohol dehydrogenase (ABAD) inhibitors for the treatment of Alzheimer's disease","volume":"62","author":"Morsy","year":"2019","journal-title":"Journal of Medicinal Chemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb1100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109130_bb1105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137030","article-title":"Evidence for the role of mitochondrial DNA release in the inflammatory response in neurological disorders","volume":"22","author":"Moya","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","article-title":"Targeting antioxidants to mitochondria by conjugation to lipophilic cations","volume":"47","author":"Murphy","year":"2007","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb1115","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1046\/j.1471-4159.1994.63062179.x","article-title":"Cortical cytochrome oxidase activity is reduced in Alzheimer's disease","volume":"63","author":"Mutisya","year":"1994","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1120","first-page":"43","article-title":"Alzheimer's disease puzzle: Delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging and Disease"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2019.09.015","article-title":"Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: A pilot study","volume":"86","author":"Neth","year":"2020","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-131901","article-title":"Long-term metformin usage and cognitive function among older adults with diabetes","volume":"41","author":"Ng","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.32607\/actanaturae.11723","article-title":"The Role of a pathological interaction between beta-amyloid and mitochondria in the occurrence and development of Alzheimer's disease","volume":"14","author":"Nikolaeva","year":"2022","journal-title":"Acta Naturae"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3233\/JAD-190853","article-title":"Mitochondrial transfer ameliorates cognitive deficits, neuronal loss, and gliosis in Alzheimer's disease mice","volume":"72","author":"Nitzan","year":"2019","journal-title":"Journal of Alzheimer's Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/NEN.0b013e318248e614","article-title":"The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons","volume":"71","author":"Nunomura","year":"2012","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb1150","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Current Alzheimer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1155","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11357-023-00999-9","article-title":"A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment","volume":"46","author":"Orr","year":"2024","journal-title":"Geroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109130_bb1160","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nature Reviews. Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb1170","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081111","article-title":"Partial inhibition of complex I restores mitochondrial morphology and mitochondria-ER communication in hippocampus of APP\/PS1 mice","volume":"12","author":"Panes","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1165","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3389\/fphar.2020.00709","article-title":"Changes in PGC-1alpha\/SIRT1 signaling impact on mitochondrial homeostasis in amyloid-beta peptide toxicity model","volume":"11","author":"Panes","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101795","article-title":"The effect of ApoE epsilon4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: A FDG-PET study","volume":"22","author":"Paranjpe","year":"2019","journal-title":"Neuroimage Clin"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb1185","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jnc.12984","article-title":"Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells","volume":"132","author":"Park","year":"2015","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jnc.12361","article-title":"Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells","volume":"127","author":"Park","year":"2013","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101947","article-title":"NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases","volume":"41","author":"Park","year":"2021","journal-title":"Redox Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5498\/wjp.v8.i2.51","article-title":"Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders","volume":"8","author":"Parkin","year":"2018","journal-title":"World J Psychiatry"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109130_bb1200","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","article-title":"Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization","volume":"91","author":"Pellerin","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109130_bb1205","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.15252\/embj.201796797","article-title":"Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease","volume":"36","author":"Pera","year":"2017","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1210","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fnins.2018.00441","article-title":"Contribution of tau pathology to mitochondrial impairment in neurodegeneration","volume":"12","author":"Perez","year":"2018","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1215","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-physiol-021115-105011","article-title":"Mito-morphosis: Mitochondrial fusion, fission, and cristae remodeling as key mediators of cellular function","volume":"78","author":"Pernas","year":"2016","journal-title":"Annual Review of Physiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-510X(77)90073-9","article-title":"Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue","volume":"34","author":"Perry","year":"1977","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0197-4580(94)90152-X","article-title":"Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study","volume":"15","author":"Pettegrew","year":"1994","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb1230","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41580-018-0092-0","article-title":"Mitochondrial proteins: From biogenesis to functional networks","volume":"20","author":"Pfanner","year":"2019","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb1235","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41593-024-01737-w","article-title":"Proteomic changes in Alzheimer's disease associated with progressive Abeta plaque and tau tangle pathologies","volume":"27","author":"Pichet Binette","year":"2024","journal-title":"Nature Neuroscience"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb1240","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.15252\/emmm.201303671","article-title":"Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB","volume":"6","author":"Polito","year":"2014","journal-title":"EMBO Molecular Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb1245","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1111\/jcmm.15194","article-title":"Mitochondrial biogenesis: An update","volume":"24","author":"Popov","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb1250","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3233\/JAD-140444","article-title":"Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease","volume":"42","author":"Porquet","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1255","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/2013.jamaneurol.286","article-title":"Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease","volume":"70","author":"Protas","year":"2013","journal-title":"JAMA Neurology"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109130_bb1260","doi-asserted-by":"crossref","DOI":"10.3390\/nu17152557","article-title":"Resveratrol as a therapeutic agent in Alzheimer's disease: Evidence from clinical studies","volume":"17","author":"Puranik","year":"2025","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11011-018-0348-6","article-title":"Intracerebroventricular injection of resveratrol ameliorated A\u03b2-induced learning and cognitive decline in mice","volume":"34","author":"Qi","year":"2019","journal-title":"Metabolic Brain Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1270","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-025-00815-2","article-title":"The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer's disease","volume":"20","author":"Quan","year":"2025","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1280","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-190964","article-title":"Amyloid-beta causes mitochondrial dysfunction via a Ca2+-driven upregulation of oxidative phosphorylation and superoxide production in cerebrovascular endothelial cells","volume":"75","author":"Quintana","year":"2020","journal-title":"Journal of Alzheimer's Disease"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb1285","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41582-025-01123-5","article-title":"Amyloid-lowering immunotherapies for Alzheimer disease: Current status and future directions","volume":"21","author":"Rafii","year":"2025","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1290","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102255","article-title":"Unveiling the interplay of AMPK\/SIRT1\/PGC-1\u03b1 axis in brain health: Promising targets against aging and NDDs","volume":"96","author":"Rakshe","year":"2024","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1295","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1297984","article-title":"Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease","volume":"17","author":"Ramezani","year":"2023","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molcel.2021.11.012","article-title":"Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex","volume":"82","author":"Rasool","year":"2022","journal-title":"Molecular Cell"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109130_bb1305","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.celrep.2016.02.006","article-title":"Dysregulation of nutrient sensing and CLEARance in presenilin deficiency","volume":"14","author":"Reddy","year":"2016","journal-title":"Cell Reports"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb1310","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/hmg\/ddx052","article-title":"Mitochondria-targeted small molecule SS31: A potential candidate for the treatment of Alzheimer's disease","volume":"26","author":"Reddy","year":"2017","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109130_bb1315","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3233\/JAD-170988","article-title":"Synergistic protective effects of mitochondrial division inhibitor 1 and mitochondria-targeted small peptide SS31 in Alzheimer's disease","volume":"62","author":"Reddy","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1320","article-title":"Mitochondria in Alzheimer's disease pathogenesis","volume":"14","author":"Reiss","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1325","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.875989","article-title":"Age-Dependent alterations of cognition, mitochondrial function, and beta-amyloid deposition in a murine model of Alzheimer's disease-a longitudinal study","volume":"14","author":"Reutzel","year":"2022","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1330","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-131715","article-title":"Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi","volume":"40","author":"Rice","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1335","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1452696","article-title":"PGC-1alpha, inflammation, and oxidative stress: An integrative view in metabolism","volume":"2020","author":"Rius-Perez","year":"2020","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1340","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/acel.12183","article-title":"Upregulation of PGC-1alpha expression by Alzheimer's disease-associated pathway: Presenilin 1\/amyloid precursor protein (APP)\/intracellular domain of APP","volume":"13","author":"Robinson","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnmol.2018.00003","article-title":"Mitochondrial division inhibitor 1 (mdivi-1) protects neurons against excitotoxicity through the modulation of mitochondrial function and intracellular Ca(2+) signaling","volume":"11","author":"Ruiz","year":"2018","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1350","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.stem.2020.10.015","article-title":"CRISPR-mediated induction of neuron-enriched mitochondrial proteins boosts direct glia-to-neuron conversion","volume":"28","author":"Russo","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13195-024-01552-2","article-title":"A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease","volume":"16","author":"Sakimura","year":"2024","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1360","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33052","article-title":"Presenilin mutations deregulate mitochondrial Ca(2+) homeostasis and metabolic activity causing neurodegeneration in Caenorhabditis elegans","volume":"7","author":"Sarasija","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1365","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2016.05.026","article-title":"Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity","volume":"1646","author":"Sarkar","year":"2016","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1370","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031030","article-title":"Human-induced neurons from presenilin 1 mutant patients model aspects of Alzheimer's disease pathology","volume":"21","author":"Schrank","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb1380","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.3390\/ijms131012629","article-title":"The role of glucose transporters in brain disease: diabetes and Alzheimer's Disease","volume":"13","author":"Shah","year":"2012","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1385","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/1570159X20666220810114644","article-title":"mtDNA maintenance and alterations in the pathogenesis of neurodegenerative diseases","volume":"21","author":"Shang","year":"2023","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101128","article-title":"Inter and Intracellular mitochondrial trafficking in health and disease","volume":"62","author":"Shanmughapriya","year":"2020","journal-title":"Ageing Research Reviews"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1395","first-page":"1479","article-title":"Cholinesterase inhibitors as Alzheimer's therapeutics (Review)","volume":"20","author":"Sharma","year":"2019","journal-title":"Molecular Medicine Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1400","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1471-4159.2011.07581.x","article-title":"Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease","volume":"120","author":"Sheng","year":"2012","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1405","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-024-01665-8","article-title":"Cerebrospinal fluid beta2-microglobulin promotes the tau pathology through microglia-astrocyte communication in Alzheimer's disease","volume":"17","author":"Sheng","year":"2025","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1410","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2018.03.010","article-title":"VDAC1, mitochondrial dysfunction, and Alzheimer's disease","volume":"131","author":"Shoshan-Barmatz","year":"2018","journal-title":"Pharmacological Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb1415","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.410350507","article-title":"Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease","volume":"35","author":"Simpson","year":"1994","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb1420","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109130_bb1425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914960","article-title":"Unveiling novel avenues in mTOR-targeted therapeutics: advancements in glioblastoma treatment","volume":"24","author":"Singh","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1430","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102732","article-title":"Mitophagy in Alzheimer's disease and other metabolic disorders: A focus on mitochondrial-targeted therapeutics","volume":"108","author":"Skawratananond","year":"2025","journal-title":"Ageing Research Reviews"},{"issue":"52","key":"10.1016\/j.pharmthera.2026.109130_bb1435","doi-asserted-by":"crossref","first-page":"30670","DOI":"10.1074\/jbc.M115.691493","article-title":"The voltage-dependent anion channel 1 mediates amyloid beta toxicity and represents a potential target for Alzheimer disease therapy","volume":"290","author":"Smilansky","year":"2015","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1440","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-024-00409-w","article-title":"Focusing on mitochondria in the brain: From biology to therapeutics","volume":"13","author":"Song","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1445","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410130116","article-title":"Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain","volume":"13","author":"Sorbi","year":"1983","journal-title":"Annals of Neurology"},{"issue":"7684","key":"10.1016\/j.pharmthera.2026.109130_bb1450","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature25143","article-title":"Enhancing mitochondrial proteostasis reduces amyloid-beta proteotoxicity","volume":"552","author":"Sorrentino","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1455","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-170139","article-title":"Decreased methylation of the mitochondrial D-loop region in late-onset Alzheimer's disease","volume":"59","author":"Stoccoro","year":"2017","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1460","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/JAD-180661","article-title":"Astrocyte- and microglia-specific mitochondrial DNA deletions levels in sporadic Alzheimer's disease","volume":"67","author":"Strobel","year":"2019","journal-title":"Journal of Alzheimer's Disease"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109130_bb1465","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1523\/JNEUROSCI.0739-06.2006","article-title":"Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice","volume":"26","author":"Stutzmann","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1470","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136011","article-title":"Genetically and pharmacologically limiting RyR2 open time prevents neuronal hyperactivity of hippocampal CA1 neurons in brain slices of 5xFAD mice","volume":"758","author":"Sun","year":"2021","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1475","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3233\/JAD-230406","article-title":"The effects of medium chain triglyceride for Alzheimer's disease related cognitive impairment: A systematic review and meta-analysis","volume":"94","author":"Sun","year":"2023","journal-title":"Journal of Alzheimer's Disease"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb1480","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tins.2014.05.008","article-title":"Calcium signaling in axon guidance","volume":"37","author":"Sutherland","year":"2014","journal-title":"Trends in Neurosciences"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109130_bb1485","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071006","article-title":"The beneficial effect of mitochondrial transfer therapy in 5XFAD mice via liver-serum-brain response","volume":"12","author":"Sweetat","year":"2023","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109130_bb1490","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1089\/ars.2011.4149","article-title":"Mitochondria and cell bioenergetics: Increasingly recognized components and a possible etiologic cause of Alzheimer's disease","volume":"16","author":"Swerdlow","year":"2012","journal-title":"Antioxidants & Redox Signaling"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1495","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and mitochondrial cascades in Alzheimer's disease","volume":"62","author":"Swerdlow","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1500","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.irn.2020.01.008","article-title":"The mitochondrial hypothesis: Dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease","volume":"154","author":"Swerdlow","year":"2020","journal-title":"International Review of Neurobiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1505","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-221286","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis: A current overview","volume":"92","author":"Swerdlow","year":"2023","journal-title":"Journal of Alzheimer's Disease"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb1510","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb1515","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00204-015-1556-z","article-title":"Oxidative stress in Alzheimer disease and mild cognitive impairment: Evidence from human data provided by redox proteomics","volume":"89","author":"Swomley","year":"2015","journal-title":"Archives of Toxicology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb1520","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/clpt.2014.174","article-title":"Serendipity and the discovery of novel compounds that restore mitochondrial plasticity","volume":"96","author":"Szeto","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1525","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1038\/s41467-025-62021-4","article-title":"Oligomer-based functions of mitochondrial porin","volume":"16","author":"Takeda","year":"2025","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1530","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.freeradbiomed.2014.07.034","article-title":"Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1\/AMPK and the Nrf2\/antioxidant defense pathways in a rat periodontitis model","volume":"75","author":"Tamaki","year":"2014","journal-title":"Free Radical Biology & Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1535","doi-asserted-by":"crossref","first-page":"27","DOI":"10.15252\/embr.201540614","article-title":"ApoE4 upregulates the activity of mitochondria-associated ER membranes","volume":"17","author":"Tambini","year":"2016","journal-title":"EMBO Reports"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb1540","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41419-022-05324-4","article-title":"Protein synthesis inhibition and loss of homeostatic functions in astrocytes from an Alzheimer's disease mouse model: A role for ER-mitochondria interaction","volume":"13","author":"Tapella","year":"2022","journal-title":"Cell Death & Disease"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb1550","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/ene.15246","article-title":"Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease","volume":"29","author":"Terada","year":"2022","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1545","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-021-00448-1","article-title":"Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease","volume":"16","author":"Terada","year":"2021","journal-title":"Molecular Neurodegeneration"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb1555","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1476-5381.2009.00316.x","article-title":"The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-\/- myopathic mice","volume":"157","author":"Tiepolo","year":"2009","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109130_bb1560","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/EBC20170104","article-title":"Mitochondrial dynamics: overview of molecular mechanisms","volume":"62","author":"Tilokani","year":"2018","journal-title":"Essays in Biochemistry"},{"issue":"11 Pt B","key":"10.1016\/j.pharmthera.2026.109130_bb1565","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bbamcr.2018.07.018","article-title":"Calcium signaling in Alzheimer's disease & therapies","volume":"1865","author":"Tong","year":"2018","journal-title":"Biochimica et Biophysica Acta, Molecular Cell Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032737","article-title":"Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease","volume":"7","author":"Trushina","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1575","doi-asserted-by":"crossref","first-page":"358","DOI":"10.38212\/2224-6614.3462","article-title":"Urolithin A exhibits a neuroprotective effect against Alzheimer's disease by inhibiting DYRK1A activity","volume":"31","author":"Tu","year":"2023","journal-title":"Journal of Food and Drug Analysis"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1580","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109130_bb1585","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1074\/jbc.M109.060061","article-title":"AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism","volume":"285","author":"Vingtdeux","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109130_bb1590","doi-asserted-by":"crossref","DOI":"10.3390\/biom12121891","article-title":"Calcium overload and mitochondrial metabolism","volume":"12","author":"Walkon","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1620","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-020-00384-6","article-title":"Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease","volume":"15","author":"Wang","year":"2020","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1610","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4732837","article-title":"Transcription factor EB is selectively reduced in the nuclear fractions of Alzheimer's and amyotrophic lateral sclerosis brains","volume":"2016","author":"Wang","year":"2016","journal-title":"Neuroscience Journal"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1630","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135598","article-title":"PGC-1\u03b1 reduces Amyloid-\u03b2 deposition in Alzheimer's disease: Effect of increased VDR expression","volume":"744","author":"Wang","year":"2021","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1650","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/CH-242100","article-title":"Activation of Pink1\/Parkin-mediated mitochondrial autophagy alleviates exertional heat stroke-induced acute lung injury in rats","volume":"88","author":"Wang","year":"2024","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1655","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jare.2025.01.007","article-title":"Calcium signaling hypothesis: A non-negligible pathogenesis in Alzheimer's disease","volume":"77","author":"Wang","year":"2025","journal-title":"Journal of Advanced Research"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1635","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113412","article-title":"The role of microglia immunometabolism in neurodegeneration: Focus on molecular determinants and metabolic intermediates of metabolic reprogramming","volume":"153","author":"Wang","year":"2022","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1660","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41422-025-01203-7","article-title":"Mitophagy in the pathogenesis and management of disease","volume":"36","author":"Wang","year":"2026","journal-title":"Cell Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb1605","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cmet.2013.03.016","article-title":"Metabolic stress modulates Alzheimer's beta-secretase gene transcription via SIRT1-PPARgamma-PGC-1 in neurons","volume":"17","author":"Wang","year":"2013","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1640","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","article-title":"The mitophagy pathway and its implications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109130_bb1615","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1093\/hmg\/ddx299","article-title":"Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model","volume":"26","author":"Wang","year":"2017","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1625","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: Recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Molecular Neurodegeneration"},{"issue":"28","key":"10.1016\/j.pharmthera.2026.109130_bb1600","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","article-title":"Impaired balance of mitochondrial fission and fusion in Alzheimer's disease","volume":"29","author":"Wang","year":"2009","journal-title":"The Journal of Neuroscience"},{"issue":"49","key":"10.1016\/j.pharmthera.2026.109130_bb1595","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","volume":"105","author":"Wang","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109130_bb1645","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.462","article-title":"The role of mitochondrial dynamics in disease","volume":"4","author":"Wang","year":"2023","journal-title":"MedComm"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109130_bb1665","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1002\/alz.13065","article-title":"Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond","volume":"19","author":"Webber","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1670","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fnins.2015.00430","article-title":"Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment","volume":"9","author":"Weinberg","year":"2015","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1675","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","article-title":"Mitochondrial diseases: From molecular mechanisms to therapeutic advances","volume":"10","author":"Wen","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1680","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Annals of Neurology"},{"issue":"4537","key":"10.1016\/j.pharmthera.2026.109130_bb1685","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"issue":"2-3","key":"10.1016\/j.pharmthera.2026.109130_bb1690","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0022-510X(82)90045-4","article-title":"Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities","volume":"57","author":"Wilcock","year":"1982","journal-title":"Journal of the Neurological Sciences"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109130_bb1695","doi-asserted-by":"crossref","DOI":"10.3390\/nu15132851","article-title":"Effect of exercise and oral niacinamide mononucleotide on improving mitochondrial autophagy in Alzheimer's disease","volume":"15","author":"Wu","year":"2023","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109130_bb1700","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4103\/1673-5374.355747","article-title":"The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer's disease","volume":"18","author":"Wu","year":"2023","journal-title":"Neural Regeneration Research"},{"issue":"43","key":"10.1016\/j.pharmthera.2026.109130_bb1705","doi-asserted-by":"crossref","first-page":"17042","DOI":"10.1523\/JNEUROSCI.1836-13.2013","article-title":"Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model","volume":"33","author":"Xie","year":"2013","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1710","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41420-023-01324-1","article-title":"Neuroprotective effect of astragalin via activating PI3K\/Akt-mTOR-mediated autophagy on APP\/PS1 mice","volume":"9","author":"Yang","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1715","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102838","article-title":"The evolution of Alzheimer's disease: From mitochondria to microglia","volume":"111","author":"Yang","year":"2025","journal-title":"Ageing Research Reviews"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109130_bb1720","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/hmg\/ddv056","article-title":"Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains","volume":"24","author":"Ye","year":"2015","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1725","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14374","article-title":"Abeta -induced excessive mitochondrial fission drives type H blood vessels injury to aggravate bone loss in APP\/PS1 mice with Alzheimer's diseases","volume":"24","author":"Zhang","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1730","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119285","article-title":"Rg1 improves Alzheimer's disease by regulating mitochondrial dynamics mediated by the AMPK\/Drp1 signaling pathway","volume":"340","author":"Zhang","year":"2025","journal-title":"Journal of Ethnopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109130_bb1735","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41401-024-01359-9","article-title":"The correlation between mitochondria-associated endoplasmic reticulum membranes (MAMs) and Ca(2+) transport in the pathogenesis of diseases","volume":"46","author":"Zhao","year":"2025","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.109130_bb1740","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107770","article-title":"Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges","volume":"216","author":"Zhou","year":"2025","journal-title":"Pharmacological Research"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109130_bb1745","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1016\/j.cell.2025.07.021","article-title":"Principles of cotranslational mitochondrial protein import","volume":"188","author":"Zhu","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109130_bb1750","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12974-023-02722-z","article-title":"Amyloid-beta accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism","volume":"20","author":"Zysk","year":"2023","journal-title":"Journal of Neuroinflammation"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:47:16Z","timestamp":1792018036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826001579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":349,"alternative-id":["S0163725826001579"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109130","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction in Alzheimer\u2019s disease: mechanisms, pathogenic interplay, and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Rutgers, The State University of New Jersey. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109130"}}